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Abstract 
In the mouse postoperative ileus model, we have shown an increase in oxidative stress after 
intestinal manipulation occurring earlier in the mucosa than in the muscular layer, which 
might contribute to epithelial barrier dysfunction. To address these findings in vitro, we 
assessed TNF-α/cycloheximide (CHX)-induced oxidative stress and apoptosis in a mouse 
intestinal epithelial cell line, MODE-K. The influence of heme oxygenase (HO)-1-related 
products and agents known to reduce reactive oxygen species (ROS) production on  
TNF-α/CHX-induced oxidative stress and apoptosis were investigated. MODE-K cells were 
exposed to different concentrations of TNF-α/CHX in the absence/presence of the test agents. 
Cell viability, caspase-3/7 activity, apoptosis, reduced glutathione level (GSH) and 
intracellular ROS production were measured. TNF-α/CHX decreased cell viability, increased 
caspase-3/7 activity, induced apoptosis, reduced the GSH level and increased ROS production 
in a concentration-dependent manner in MODE-K cells. All these effects of TNF-α/CHX 
were partially prevented by pretreatment with a carbon monoxide-releasing agent (CORM-
A1) and nitrite. The antioxidant resveratrol abolished TNF-α/CHX-induced increase in ROS 
production and caspase-3/7 activity, but apoptosis was only partially prevented. MODE-K 
cells are sensitive to TNF-α-induced apoptosis in the presence of CHX, which is associated 
with increased intracellular ROS production and caspase-3/7 activation. The effects were 
partially mitigated by CORM-A1, nitrite and resveratrol. Thus, these agents could be of 
potential use in protecting the epithelial barrier against oxidative stress during intestinal 
ischemia/reperfusion injury. 
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INTRODUCTION 
 
Sepsis is an infection with a systemic inflammatory response syndrome, that can progress to 
multiple organ failure and septic shock. This complex disorder is triggered by an 
inflammatory cascade initiated by bacteria-derived molecules such as endotoxin, with 
subsequent formation of endogenous inflammatory cytokines such as tumor necrosis factor 
(TNF)-α, leading to ischemia/reperfusion, mitochondrial dysfunction and apoptosis [1]. The 
gut is a triggering factor in the progression of sepsis [2]. Severe stress caused by conditions 
such as major trauma, burns, hemorrhagia and major surgery leads to intestinal 
ischemia/reperfusion and local production of pro-inflammatory cytokines, that contribute to 
the systemic inflammation. In addition, ischemia/reperfusion causes disturbance of the 
intestinal epithelial barrier and bacterial translocation [3], which is facilitated by impairment 
of bowel motility (ileus) [4]. The mechanism of sepsis-induced ileus, assessed by injecting 
endotoxins in animal models, shows similarity to postoperative ileus occurring after 
abdominal surgery, as endotoxin exposure or intestinal manipulation results in activation of 
the resident macrophages in the intestinal muscle, leading to production of pro-inflammatory 
cytokines such as TNF-α, chemokines and adhesion molecules. The latter are essential for 
further recruitment of circulatory leukocytes into the intestinal muscularis [5]. The mucosal 
layer seems a victim rather than an instigator in the pathogenesis of ileus. 
Notably, in a mouse model of postoperative ileus we recently reported an early and transient 
increase in oxidative stress in the mucosal layer, with a peak value at 1 h after intestinal 
manipulation, preceding the peak in the muscularis [6]. The combination of oxidative stress-
induced epithelial cell damage, increased intestinal permeability and translocation of 
intraluminal endotoxins might trigger the muscular inflammation [7]; TNF-α may play a role 
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in this epithelial distress. When combined with the protein synthesis inhibitor cycloheximide 
(CHX), TNF-α was shown to initiate apoptosis in isolated gastrointestinal epithelial cells 
[8,9]. Moreover, TNF-α/CHX-induced oxidative stress has been implicated in intestinal 
epithelial cell apoptosis [10]. To our knowledge, no in vitro study has yet fully explored 
TNF/CHX-α-induced apoptosis in a murine epithelial cell line. The murine intestinal 
epithelial cell line MODE-K is an undifferentiated cell line, which has the advantage of not 
being derived from tumor tissue, but from the duodenum-jejunum from normal young mice. 
Hence, it is considered to be an important model exhibiting phenotypic and functional 
properties of normal mouse enterocytes [11,12]. The first aim of our present study was to 
investigate the relationship between oxidative stress and apoptosis by TNF-α/CHX in MODE-
K cells. 
Heme oxygenase (HO) is an ubiquitous rate limiting enzyme that catabolizes heme into 
ferrous iron, carbon monoxide (CO) and biliverdin, which is subsequently reduced to 
bilirubin. The stress inducible isoform HO-1, which is upregulated by numerous stimuli 
including oxidative stress and proinflammatory cytokines [13], serves as a cytoprotective 
gene by virtue of its potent antioxidant, anti-apoptotic and anti-inflammatory properties [14]. 
Biliverdin and its end product bilirubin are potent antioxidants and were shown to have 
cytoprotective effects [15,16]. Accumulating evidence indicates that also CO can mediate 
many of the biological functions of HO-1 [15]. Accordingly, CO-releasing molecules (CO-
RMs) have been developed to deliver CO in a controllable manner under physiological 
conditions providing an advantage of reduced risk of systemic toxicity [17,18,19]. The water 
soluble CO-RMs (CORM-3 and CORM-A1) [20,21] have gained increasing interest recently 
due to their promising pharmacological properties as carriers of therapeutic doses of CO in 
models of disease including gastrointestinal disorders [22,23]. Indeed, in a murine model of 
postoperative ileus, we have shown that the “fast” CO releaser CORM-3 markedly reduced 
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the manipulation-induced inflammation of the muscularis and improved surgically induced 
intestinal dysmotility. This was accompanied by reduction of the early oxidative burst in the 
mucosa [6]. The second aim of our present study was therefore to investigate the influence of 
HO-1-related products (bilirubin, biliverdin and CO-RMs) on the oxidative/apoptotic 
response of the MODE-K cell line to TNF-α/CHX. For comparison, several agents that are 
known to reduce the excessive production of reactive oxygen species (ROS) were also tested: 
apocynin and diphenylene iodonium (DPI), which can inhibit nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase activity; nitrite, that can inhibit mitochondrial ROS 
production [24]; Mito-TEMPO, a mitochondria-targeted antioxidant; and dimethyloxallyl 
glycine (DMOG), a prolyl hydroxylase inhibitor, that attenuates hypoxia-induced intestinal 
mucosal inflammation [25] and decreases hypoxia-induced ROS production in a human 
synovial cell line [26]. Finally, resveratrol, a cytoprotective bioactive polyphenol present in 
red wine, was tested given its potential to attenuate intestinal ischemia/reperfusion injury [27] 
and its HO-1 related neuroprotective action against stroke [28]. 
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MATERIALS AND METHODS 
 
Chemicals and reagents 
Bilirubin, biliverdin (biliverdin IX hydrochloride) and cobalt protoporphyrin IX (CoPP) were 
purchased from Frontier Scientific Europe Ltd. (Carnforth, UK). 2-(2,2,6,6-
tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) triphenylphosphonium chloride 
monohydrate (Mito-TEMPO) was purchased from Enzo Life Sciences. Apocynin, 
cycloheximide, dimethyloxallyl glycine (DMOG), dimethyl sulfoxide (DMSO), diphenylene 
iodonium (DPI), nitrite (as sodium nitrite), propidium iodide, resveratrol and ribonuclease-A 
were obtained from Sigma (St. Louis, MO, USA). Recombinant murine TNF-α was purchased 
from R&D system (Minneapolis, MN, USA). Fetal bovine serum, Dulbecco’s modified 
Eagle’s medium (DMEM), penicillin/streptomycin, and glutamax were obtained from Gibco 
BRL (Grand Island, NY, USA). All other chemicals were reagent grade and obtained from 
Sigma unless otherwise stated. 
 
Cell culture 
The mouse small intestinal epithelial cell (IEC) line, MODE-K (a generous gift from Dr. Ingo 
B. Autenrieth, University of Tübingen, Germany) was used in our study. These are small 
IECs from C3H/HeJ mice immortalized by simian virus (SV)-40 large T gene transfer, 
exhibiting morphological and phenotypic characteristics of normal enterocytes [29]. MODE-
K cells (passage 10–35) were cultured in high-glucose DMEM supplemented with 10% fetal 
bovine serum, 2 mM L-glutamine, and 5% penicillin/streptomycin. Cultures were maintained 
in a humidified 5% CO2 atmosphere at 37°C and experiments were conducted on cells at 
approximately 80-90% confluence. MODE-K cells were seeded at either 3.5 x 10
5
 cells per 2 
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mL of culture medium containing 10% serum in a six-well plate (for apoptosis assay) or at 1 x 
10
4
 cells per 200 µL of culture medium in a 96-well microtiter plate (for all other assays), 
grown for 36 h and then serum starved overnight. On day 3, cells were treated with various 
concentrations of TNF-α/cycloheximide (CHX) for 0-6 h. Test drugs were pre-incubated for 1 
h followed by co-incubation of drugs with various concentrations of TNF-α/CHX for 3-6 h, 
with the exception of CoPP that was incubated for 3 h from 24 h till 21 h before exposure to 
TNF-α/CHX. The influence of test drugs alone on cell viability was studied on day 3 by 
incubating MODE-K cells for 12 h. 
 
Determination of cell viability 
Cell viability was assessed by luminescent cell viability assay with CellTiter-Glo (Promega, 
Madison, WI, USA) according to the manufacturer's
 
protocol. This assay determines the 
number of viable cells in culture based on quantitation of ATP present, an indicator of 
metabolically active cells. Briefly, MODE-Κ cells were plated into 96-well plates and treated 
as described under cell culture. At the end of the incubation period with agents on day 3, an 
equivolume of the luminescent substrate and lysis buffer mix from the assay kit was added. 
The mixture was transferred to an opaque 96-well plate and luminescence was recorded using 
a GloMax Microplate Luminometer (Promega). The index of cellular viability was calculated 
as percentage of luminescence with respect to untreated control cells. 
 
Measurement of caspase-3/7 activity 
Caspase-3/7 activity was determined using the chemiluminescent Caspase-Glo 3/7 Assay 
(Promega, Madison, WI, USA) according to the manufacturer’s instructions. The assay 
provides a luminogenic caspase-3/7 substrate, which contains the tetrapeptide sequence 
DEVD, in a reagent optimized for caspase activity, luciferase activity, and cell lysis. Briefly, 
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MODE-Κ cells were plated into 96-well plates and treated as described under cell culture. 
After incubation, an equivolume of luminescent caspase-3/7 Glo substrate buffer was then 
added followed by gentle agitation for 30 min. The mixture was transferred to an opaque 96-
well plate and luminescence was recorded using a GloMax Microplate Luminometer 
(Promega). Relative luminescence units were noted and the results are expressed as 
percentage of luminescence with respect to untreated control. 
 
Flow cytometry analysis of apoptosis 
Cellular DNA content and apoptosis were analyzed by flow cytometry as described 
previously [30]. Briefly, cells were plated into six-well plates and after treatment for the 
indicated time, the cells were rinsed with PBS, harvested and then fixed by the progressive 
addition of ice-cold 70% ethanol. The fixed cells were washed twice with PBS before staining 
with propidium iodide (PI) at 100 µg·mL
-1
 and RNase at 50 µg·mL
-1
 in PBS for 20 min. Cell 
viability was determined by flow cytometry (FACSCalibur, BD Bioscience, NJ) and 
CellQuest software (Becton Dickinson, San Jose, CA, USA). Cell debris was excluded from 
analysis by appropriate raising of the forward scatter threshold. The percentage of cells that 
had undergone apoptosis was assessed to be the ratio of the fluorescent area smaller than the 
G0-G1 peak to the total area of fluorescence. The average of the results from at least three 
samples for each experimental condition is presented. 
 
Measurement of intracellular reduced glutathione (GSH) levels 
The intracellular content of reduced glutathione (GSH) was quantified using the 
bioluminescent GSH-Glo Glutathione Assay (Promega, Madison, WI, USA), essentially as 
recommended by the supplier. In brief, MODE-Κ cells were plated into 96-well plates and 
treated with TNF-α/CHX ± test drugs as described above. After incubation, adherent cells 
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were directly lysed in 100 μl GSH-Glo lysis and reaction buffer. After addition of 100 μl 
GSH-Glo Luciferin detection reagent, the mixture was transferred to an opaque 96-well plate 
and luminescence was detected using a GloMax Microplate Luminometer (Promega). The 
GSH levels of treated cells are expressed as percentage of the value in untreated control cells. 
 
Measurement of intracellular reactive oxygen species (ROS) generation 
The intracellular ROS level was detected using 5-(and-6)-carboxy-2′,7′-
dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA) (Molecular Probes, Eugene, OR, 
USA) as reported [31]. Carboxy-H2DCFDA is a cell-permeable indicator for ROS that is 
nonfluorescent until the acetate groups are removed by intracellular esterases and oxidation 
occurs within the cell. When oxidized by various active oxygen species, it is irreversibly 
converted to the fluorescent form, DCF. The fluorescence generated by DCF is proportional 
to the rate of carboxy-H2DCFDA oxidation, which is in turn indicative of the cellular 
oxidizing activity and intracellular ROS levels. For ROS measurements, briefly, MODE-Κ 
cells were plated
 
into black 96-well plates and treated as described. Cells were washed twice 
in Hanks’ balanced salt solution (HBSS) and then incubated in HBSS containing carboxy-
H2DCFDA (10 μM) for 40 min in the dark at 37°C. Fluorescence was measured using an 
excitation of 485 nm and emission of 530 nm, in a fluorescence plate reader (Wallac 
EnVision 2101 multilabel reader, Perkin Elmer, Zaventem, Belgium). Basal ROS generation 
in the cells treated without the stimulus was used as a control. 
 
Western blotting 
Total cell extracts were prepared using RIPA buffer and protein concentrations were 
measured with the BCA protein assay reagent (Pierce). Equal amounts of protein (20 μg) were 
loaded onto NuPAGE-Novex 4 to 12% Bis-Tris electrophoresis gels (Invitrogen) and blotted 
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onto nitrocellulose membranes (GE Healthcare, Little Chalfont, Buckinghamshire, UK). 
Membranes were blocked in Tris-buffered saline/0.1% Tween 20 containing 5% nonfat dry 
milk and incubated overnight with appropriate antibodies for the detection of HO-1 (cat. no. 
sc-10789, 1:1000; Santa Cruz Biotechnology, Santa Cruz, CA) and β-tubulin (cat. no. ab6046, 
1:1000; Abcam, Cambridge, UK). Horseradish peroxidase-linked secondary antibodies (Cell 
Signaling Technology Inc., Danvers, MA) were visualized by use of Amersham ECL Prime 
Substrate (GE Healthcare Life Sciences). Densitometry of the bands was performed using 
Image J software (National Institutes of Health, Bethesda, MD). 
 
Statistical analysis 
All data were expressed as mean ± SEM. Comparison of the means was performed using the 
Student’s t-test for two groups of data and ANOVA followed by Bonferroni’s multiple 
comparison test for comparison of more than two groups. Differences were considered to be 
significant at P < 0.05. 
 
RESULTS 
 
Influence of TNF-α/CHX on cell viability 
The aim of the first set of experiments was to assess the sensitivity of MODE-K cells to the 
cytotoxic effect of TNF-α by testing its influence on cell viability. TNF-α is a cytokine 
inducing apoptosis but many cell lines only undergo apoptosis when TNF-α is combined with 
an agent such as CHX. Previous observations in MODE-K cells showed that TNF-α per se in 
concentrations up to 10 ng·mL
-1
 and incubated for up to 24 h did not induce cell death [32]. 
We therefore first tested the apoptotic stimulus used in other intestinal epithelial cell lines (20 
ng·mL
-1
 TNF-α plus 25 µg·mL-1 CHX) [8,33,34]. Incubation of MODE K-cells for 6 h with 
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this combination decreased cell viability to 10% of untreated cells, while neither agent alone 
influenced cell viability, the latter corresponding to data with the same concentrations of both 
agents in rat IEC-6 cells [8]. As preliminary experiments showed that the very pronounced 
effect of TNF-α (20 ng·mL-1)/CHX (25 µg·mL-1) on cell viability was not influenced by any 
of the HO-1 related products, lower concentrations of TNF-α were investigated, in 
combination with either 25 or 10 µg·mL
-1
 CHX, as 10 µg·mL
-1
 CHX is also often used in 
combination with TNF-α in cell lines [35,36,37]. This showed a high sensitivity of MODE-K 
cells to TNF-α/CHX as 0.1–1 ng·mL-1 TNF-α together with 10 µg·mL-1 CHX induced a 
concentration-dependent decrease in cell viability (to 54 ± 3% at 0.1 ng·mL
-1
 and 22 ± 1% at 
1 ng·mL
-1
 TNF-α, Fig. 1A), the effect with 1 ng·mL-1 TNF-α/10 µg·mL-1 CHX being close to 
that of 20 ng·mL
-1
 TNF-α/25 µg·mL-1 CHX. The concentration range 0.1-1 ng·mL-1 TNF-α 
was therefore studied in the assays for caspase-3/7 activity, apoptosis and oxidative stress. 
 
Influence of TNF-α/CHX on caspase-3/7 activity and apoptotic cell death 
The combination of TNF-α/CHX for 6 h induced an increase in caspase-3/7 activity in a 
concentration-dependent manner (Fig. 1B). TNF-α (0.1 ng·mL-1)/CHX (10 µg·mL-1) 
increased caspase-3/7 activity by 3.6 fold when compared to control while TNF-α  
(1 ng·mL
-1
)/CHX (10 µg·mL
-1
) increased the caspase-3/7 activity by nearly five fold. 
Concomitantly, flow cytometric analysis of propidium iodide-stained cells for apoptosis 
showed that TNF-α induced a concentration-dependent apoptotic cell death (Fig. 1C). In both 
assays, the result with TNF-α (1 ng·mL-1)/CHX (10 µg·mL-1) approached that obtained with 
TNF-α (20 ng·mL-1)/CHX (25 µg·mL-1) studied in comparison. To evaluate the kinetics of 
TNF-α/CHX-induced apoptosis, MODE-K cells were incubated with TNF-α  
(1 ng·mL
-1
)/CHX (10 µg·mL
-1
) for 0-6 h. Induction of apoptosis began after exposure to 
TNF-α/CHX for 2 h and increased further in a time-dependent manner (Fig. 1D). 
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Influence of TNF-α/CHX on reduced glutathione (GSH) and reactive oxygen species 
(ROS) levels 
As a sequential pathway of “ROS production → caspase-3 activity → apoptosis” has been 
proposed for TNF-α/CHX-induced cell death in rat IEC-6 cells [10], TNF-α/CHX-induced 
oxidative stress in MODE-K cells was assessed by measurement of intracellular ROS 
generation and of the classic antioxidant GSH. Incubation of MODE-K cells with 0.1–1 
ng·mL
-1
 TNF-α/CHX (10 µg·mL-1) for 3 h did not influence GSH levels, while TNF-α (20 
ng·mL
-1
)/CHX (25 µg·mL
-1
) significantly decreased the GSH level to 62 ± 2% of untreated 
cells (Fig. 2A). However, after 6 h of exposure, TNF-α/CHX reduced cellular GSH levels in a 
concentration-dependent manner, with 0.1 and 1 ng·mL
-1
 TNF-α decreasing GSH levels to 69 
± 3% and 44 ± 2%, respectively. TNF-α (20 ng·mL-1)/CHX (25 µg·mL-1) added for 6 h 
decreased the GSH level to 21 ± 1%. 
Incubation of cells with TNF-α/CHX for 3 h also induced a concentration-dependent increase 
in ROS production (Fig. 2B). When co-incubated with 10 µg·mL
-1
 CHX, 0.1 and 1 ng·mL
-1
 
TNF-α increased ROS production to 2.73 fold and 4.52 fold, respectively, compared to 
control. A time-course experiment with TNF-α (1 ng·mL-1)/CHX (10 µg·mL-1) showed an 
increase in ROS production starting at 2 h (Fig. 2B) illustrating that the increase in ROS 
production paralleled the induction of apoptosis. 
 
Effects of HO-1 and antioxidant-related products on TNF-α/CHX-induced decrease in 
cell viability 
To determine the highest concentration of the HO-1 and antioxidant-related products that was 
not cytotoxic per se, MODE-K cells were incubated with increasing concentrations of each 
compound for 12 h (n = 3 for each compound, data not shown). This concentration was then 
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tested on the decrease in cell viability by 0.1–1 ng·mL-1 TNF-α/10 µg·mL-1 CHX to screen 
for the protective effects versus the cytotoxic action of TNF-α/CHX. 
As for the HO-1 related products, 100 µM of bilirubin and 3 µM of biliverdin did not 
influence TNF-α/CHX-induced decrease in cell viability (data not shown), but 1 µM of 
bilirubin partially protected against 0.1 and 0.25 ng·mL
-1
 TNF-α/CHX (Fig. 3A). CORM-A1 
(100 µM) and CORM-3 (100 µM) induced significant partial protection from cell death at all 
concentrations of TNF-α/CHX tested (Fig. 3B-C). The most effective CORM (CORM-A1) 
and the low concentration of bilirubin were selected for further study. 
With regard to the antioxidant-related products, apocynin (250 µM), MitoTEMPO (1 µM) and 
DMOG (500 µM) did not influence the decrease in cell viability by TNF-α/CHX (data not 
shown). However, DPI (100 µM) showed prevention from TNF-α-induced cytotoxicity at 0.1-
0.5 ng·mL
-1
 TNF-α/CHX, while nitrite (10 mM) showed cytoprotection at all tested 
concentrations of TNF-α/CHX (Fig. 3D-E). The most effective agent was resveratrol (75 
µM), which completely prevented cell death by 0.1 ng·mL
-1
 TNF-α/CHX and restored cell 
viability in the presence of 1 ng·mL
-1
 TNF-α/CHX from 22 ± 1% to 65 ± 3% (Fig. 3F). On 
the basis of these results, nitrite (10 mM) and resveratrol (75 µM) were selected to further 
examine the relation between their influence on TNF-α/CHX-induced oxidative stress and on 
TNF-α/CHX-induced apoptosis. 
 
Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in caspase-3/7 activity and apoptosis 
Treatment with 1 µM bilirubin, 100 µM CORM-A1, 10 mM nitrite or 75 µM resveratrol 
significantly attenuated the TNF-α/CHX-induced increase in caspase-3/7 activity at all tested 
concentrations of TNF-α (Fig. 4A-D). Among these agents, nitrite and resveratrol showed a 
more pronounced decrease of the induced caspase activities compared to bilirubin or CORM-
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A1. The anti-apoptotic effect was tested versus 0.1 and 1 ng·mL
-1
 TNF-α. Bilirubin was not 
effective in preventing the apoptotic cell death at both tested TNF-α concentrations, while 
CORM-A1, nitrite and resveratrol partially prevented the apoptotic cell death induced by the 
two tested concentrations of stimulus (Fig. 5A-D). The results with bilirubin illustrate that 
inhibition of TNF-α/CHX-induced caspase-3/7 activity does not necessarily result in a 
reduction of TNF-α/CHX-induced apoptosis. 
 
Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in GSH levels and ROS production 
The effect of the various agents on cellular levels of GSH were measured in the presence of 
TNF-α/CHX for 6 h. TNF-α (0.1–1 ng·mL-1)/CHX significantly reduced cellular GSH levels 
while pretreatment with 1 µM bilirubin, 100 µM CORM-A1, 10 mM nitrite or 75 µM 
resveratrol partially prevented this effect (Fig. 6A-D). We next investigated whether any of 
these agents could suppress TNF-α/CHX-induced ROS production by direct measurement of 
carboxy-H2DCFDA fluorescence. TNF-α (1 ng·mL
-1
)/CHX increased the ROS production by 
4.63 fold compared to control, which was reduced to 3.51 fold by bilirubin, 2.93 fold by 
CORM-A1, and 3.57 fold by nitrite (Fig. 7). On the other hand, resveratrol completely 
abolished the TNF-α/CHX-induced increase in ROS production. The results with CORM-A1, 
nitrite and resveratrol suggest that inhibition of TNF-α/CHX-induced ROS production can 
contribute to the anti-apoptotic effects of compounds in MODE-K cells. 
 
Effects of bilirubin, CORM-A1, nitrite and resveratrol on TNF-α/CHX-induced changes 
in HO-1 protein expression 
As induction of the expression of endogenous HO-1 has been suggested to contribute to the 
cytoprotective effects of CO-RMs and resveratrol [28,38], the expression of HO-1 was 
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assessed by Western blotting. In MODE-K cells, the baseline HO-1 protein level was 
significantly decreased by TNF-α (1 ng·mL-1)/CHX (Fig. 8). The HO-1 inducer CoPP (10 
µM) [39], used as a positive control, increased HO-1 expression markedly both in the absence 
and presence of TNF-α/CHX. Treatment with 1 µM bilirubin, 100 µM CORM-A1 or 10 mM 
nitrite did not affect basal HO-1 expression; in co-presence with TNF-α/CHX, the HO-1 level 
was not significantly different from that with TNF-α/CHX alone. Notably, 75 µM resveratrol 
per se induced HO-1 expression significantly to 1.63 fold as compared to the basal level. 
However, pretreatment of 75 µM resveratrol did not prevent the TNF-α/CHX-induced 
decrease in HO-1 protein expression. The results illustrate that HO-1 expression does not 
contribute to the cytoprotective effect of CORM-A1, nitrite and resveratrol in MODE-K cells. 
 
DISCUSSION 
 
The aim of this study was 1) to investigate the oxidative and apoptotic effects of TNF-α/CHX 
in the murine MODE-K epithelial cell line and 2) to evaluate the influence of HO-1 and 
antioxidant-related products on the oxidative/apoptotic response to TNF-α/CHX in MODE-K 
cells. 
 
Induction of oxidative stress and cell death in MODE-K cells by TNF-α 
The study showed that the MODE-K IEC line is highly sensitive to the cytotoxic effects of 
TNF-α with CHX, 0.1 ng·mL-1 TNF-α/10 µg·mL-1 CHX halving cell viability and 1 ng·mL-1 
TNF-α/10 µg·mL-1 CHX reducing cell viability to values close to that by 20 ng·mL-1  
TNF-α/25 µg·mL-1 CHX. The concentration range 0.1-1 ng·mL-1 corresponds to TNF-α 
concentrations observed in mice under pathophysiological conditions of sepsis or 
postoperative ileus. After injection of endotoxin, circulatory peak  levels of 0.78 and 2.11 
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ng·mL
-1
 TNF-α have been reported [40,41]; in mesenteric lymph derived from the 
gastrointestinal tract, still higher and more sustained TNF-α levels of approximately  
3 ng·mL
-1
 were observed [41]. After intestinal manipulation, a TNF-α level of 0.08 ng·mL-1 
was obtained in peritoneal lavage fluid [42] and of 2 ng·mL
-1
·mg
-1
 in the supernatant of 
exteriorized and cultured muscularis layer [43]. 
TNF-α/CHX-induced apoptosis occurred in parallel with ROS production. TNF-α (0.1-1 
ng·mL
-1
)/CHX treatment for 6 h induced concentration-dependent apoptosis correlating with 
its influence on cell viability. When studying the time-dependency of 1 ng·mL
-1
 TNF-α, 
apoptosis started from 2 h of TNF-α incubation on, and this corresponded with the occurrence 
of ROS production. The concentration-dependent induction of apoptosis by TNF-α at 6 h was 
accompanied by a corresponding increase in caspase-3/7 activity, so that the sequence “ROS 
production → caspase-3/7 activity → apoptosis” as reported in rat IEC-6 cells [10] might also 
occur in MODE-K cells. The concentration-dependent induction of ROS by TNF-α at 3 h was 
not paralleled by a decrease in GSH, which only occurred at 6 h. GSH is a potent intracellular 
anti-oxidant that attenuates oxidative stress, while cytochrome c is a protein located in the 
mitochondrial intermembrane space which becomes pro-apoptotic when triggered by 
increased and sustained ROS production [44]. Oxidative stress, due to ROS, can cause 
depletion of GSH levels in the mitochondria leading to the release and oxidation of 
cytochrome c to the cytosol and subsequent caspase activation. Since reduced GSH in 
mitochondria is the only defense provided to metabolize peroxides generated from the 
electron transport chain through the GSH redox cycle [45], from our observation, it seems that 
the production of ROS in the form of peroxides starts at a later time point (after 3 h) during 
TNF-α/CHX exposure, while other forms of ROS (hydroxyl radical and superoxide anion) 
might play a role in earlier apoptosis induction from 2 h of TNF-α/CHX exposure in MODE-
K cells. 
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Influence of HO-1 related products on TNF-α/CHX-induced oxidative stress and 
apoptosis 
At the highest non-cytotoxic concentration used, CORM-3 and more effectively CORM-A1 
reduced the decrease of cell viability by TNF-α, while 100 µM bilirubin or 3 µM biliverdin 
had no effect. However, at much lower concentration (1 µM), bilirubin has been shown to 
elicit antioxidant effects with significant reduction in ROS production and cell proliferation in 
human airway smooth muscle cells [46]. At this concentration, our studies revealed that 
bilirubin partially prevented cell death induced by the two lower concentrations of TNF-α 
tested; although partially preventing the TNF-α (1 ng·mL-1)/CHX-induced increase in ROS 
production and caspase-3/7 activity, bilirubin failed to show any prevention of TNF-α/CHX-
induced apoptosis. This is in agreement with a study by Basuroy et al. [36] showing that 
bilirubin had only a mild effect on TNF-α/CHX-induced apoptosis although it reduced 
caspase-3 expression in a pronounced way. The mild effect of bilirubin on TNF-α/CHX-
induced ROS-production is thus not sufficient to reduce TNF-α/CHX-induced apoptosis; 
neither is its mild effect on caspase-3/7 activity. The latter can be related to caspase-
independent pathways of TNF-α-induced apoptosis as TNF-α has been reported to also induce 
caspase-independent cell death in a variety of cells like macrophages [47], neutrophils [48] 
and, in particular, HT29 human adenocarcinoma cells [49]. 
The reduction of TNF-α/CHX-induced caspase-3/7 activity by CORM-A1 was also very mild, 
but in contrast to bilirubin, CORM-A1 was able to clearly reduce TNF-α/CHX-induced 
apoptosis. This dissociation can be attributed again to caspase-independent pathways of  
TNF-α-induced apoptosis. The exact mechanism of the anti-apoptotic effect of CORM-A1 in 
MODE-K cells remains to be clarified, but our study shows that its anti-apoptotic effect 
correlates with a reduction in ROS production, which was more pronounced than that 
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observed with bilirubin, as well as an increase in GSH levels. Indeed, caspase-independent 
induction of apoptosis by ROS has been reported in PC12 pheochromocytoma cells so that 
inhibition of ROS production per se can be expected to reduce apoptosis [50]. The finding 
that CORM-A1 exerts significant protection against both TNF-α/CHX-induced oxidative 
stress and apoptosis supports the notion that CO can mediate the well-known anti-apoptotic 
effect of HO-1. 
CO-RMs were shown to induce HO-1 expression in different types of cells [51,52] and this 
was suggested to contribute to their anti-apoptotic effect [38]. In thyroid carcinoma cells,  
HO-1 induction by hemin was shown to protect against TNF-α/CHX-induced apoptosis [53]. 
In MODE-K cells in the actual study, basal HO-1 levels were decreased by 3 h exposure to  
TNF-α plus the protein synthesis inhibitor CHX, although TNF-α alone can reduce 
endogenous HO-1 expression in some cells [54]. CoPP, a well-known HO-1 inducer as also 
confirmed in control MODE-K cells, still clearly induced HO-1 when cells were also 
incubated with TNF-α/CHX. However, this was not the case with CORM-A1, excluding the 
possibility that endogenous HO-1 induction contributes to the anti-apoptotic effect of  
CORM-A1 in MODE-K cells. Correspondingly, exogenous CO protected pancreatic β-cells 
against TNF-α-induced apoptosis even when HO-1 activity was blocked [55]. 
 
Influence of antioxidant related products on TNF-α/CHX-induced oxidative stress and 
apoptosis 
Apocynin is widely used as an NADPH oxidase inhibitor [56] and in Caco-2 cells, it was 
shown to inhibit polychlorinated biphenyls-induced NADPH oxidase activation and 
disruption of epithelial integrity [57]. However, in the present study we found that apocynin 
did not protect at all MODE-K cells from TNF-α/CHX-induced cytotoxicity. This does not 
discard the possibility that NADPH oxidase is participating to TNF-α/CHX-induced ROS 
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production in MODE-K cells since the inhibitory effect of apocynin on NADPH oxidase 
activity has been questioned [58]. Another NADPH oxidase inhibitor, DPI [59], partially 
protected MODE-K cells from TNF-α/CHX-induced cell death at lower concentrations of 
TNF-α, but not at 1 ng·mL-1 TNF-α. 
Mitochondrial ROS has also been implicated in TNF-α-induced cytotoxicity [60]. In our 
study, nitrite but not the mitochondrial-targeted antioxidant Mito-TEMPO influenced  
TNF-α/CHX-induced decrease in cell viability of MODE-K cells. The concentration of nitrite 
(10 mM) used was shown to provide complete rescue of UVA-induced apoptotic cell death in 
rat aortic endothelial cells [61]. We also found that nitrite reduced TNF-α/CHX-induced 
caspase-3/7 activation. It had a similar influence on TNF-α/CHX-induced ROS production as 
bilirubin, but in contrast to bilirubin, it also reduced TNF-α/CHX-induced apoptosis. In 
ischemia/reperfusion injury, nitrite has been shown to act by decreasing mitochondrial ROS 
generation through inhibition of complex I activity [24]. The fluorescent probe, carboxy-
H2DCFDA, used in this study as an indicator of generalized oxidative stress is not specific for 
a single type of ROS like H2O2, peroxynitrite and peroxides [62,63]. Consequently, this probe 
can detect different ROS types from mitochondria, lipid oxidation and other sources, and the 
similar degree of ROS reduction by nitrite and bilirubin does not necessarily mean that the 
same source of ROS is influenced by both agents. A more important role of mitochondrial 
ROS, rather than ROS from other sources, in the induction of apoptosis, might then explain 
why nitrite, preferentially reducing mitochondrial ROS production, is able to reduce apoptosis 
while bilirubin is not. 
Despite the hydroxylase inhibitor DMOG has been reported to protect intestinal epithelial 
cells against TNF-α-induced apoptosis in vitro [64] and to decrease hypoxia-induced ROS 
production in human synovial cells [26], it failed to prevent TNF-α/CHX-induced cell death 
in MODE-K cells. Resveratrol, a bioactive polyphenol from red wine, has shown 
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cytoprotection in many models related to interaction with multiple targets, such as, for 
example, induction of silent information regulator-1 (SIRT-1) [65]. Its attenuating effect on 
dextran sulfate sodium-induced colitis was also related to SIRT-1 induction [66]. Recently, 
induction of HO-1 was implied in the neuroprotective effect of resveratrol against stroke [28]. 
In our study, resveratrol per se increased basal HO-1 protein expression in MODE-K cells, 
but it did not prevent the decrease by TNF-α/CHX excluding HO-1 induction as the 
mechanism of action for its protective effect versus TNF-α/CHX. In MODE-K cells, 
resveratrol was by far the most effective cytoprotective agent as it fully abolished  
TNF-α/CHX-induced ROS production and caspase-3/7 activation; surprisingly, it only 
reduced apoptosis by approximately 50%. This suggests that TNF-α/CHX-induced apoptosis 
of MODE-K cells can occur in a ROS- and caspase-3/7-independent way. 
 
CONCLUSION 
 
In summary, these data indicate that mouse intestinal epithelial MODE-K cells are highly 
sensitive to TNF-α-induced apoptosis in the presence of CHX. TNF-α/CHX-induced 
apoptosis was accompanied by increased intracellular ROS generation and caspase-3/7 
activation. CORM-A1, nitrite and most importantly resveratrol attenuated TNF-α/CHX-
induced ROS production, caspase-3/7 activation and apoptosis. These agents might therefore 
be useful to prevent epithelial damage during ischemia/reperfusion injury. 
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Figure Legends 
 
Fig. (1). Influence of 0.1-1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX and of 20 ng·mL-1 TNF-α 
with 25 µg·mL
-1
 CHX, incubated for 6 h, on cell viability (as % of control; A), caspase-3/7 
activity (as % of control; B), and apoptosis (C). Control cells were incubated with serum free 
medium alone. Mean ± SEM of six independent experiments. *P < 0.05 versus control. D: 
Influence of 1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 0-6 h, on apoptosis. 
Mean ± SEM of three independent experiments. *P < 0.05 versus untreated (0 h) control 
group. 
 
Fig. (2). Influence of 0.1-1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX and of 20 ng·mL-1 TNF-α 
with 25 µg·mL
-1
 CHX, incubated for 3 h (A, B) or 6 h (A), on cellular glutathione (GSH; as 
% of control; A) and intracellular ROS levels (B). Control cells were incubated with serum 
free medium alone. Mean ± SEM of six (A) or two (B) independent experiments. 
#
P < 0.05 
versus control (for 3 h). *P < 0.05 versus control (for 6 h). C: Influence of 1 ng·mL
-1
 TNF-α 
with 10 µg·mL
-1
 CHX, incubated for 0-3 h, on intracellular ROS levels. Mean ± SEM of two 
independent experiments. *P < 0.05 versus untreated (0 h) control group. 
 
Fig. (3). Influence of 0.1-1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 6 h, on cell 
viability (as % of control) in the absence and presence of 1 µM bilirubin (BR, A), 100 µM 
CORM-A1 (B), 100 µM CORM-3 (C), 100 µM diphenylene iodonium (DPI, D), 10 mM 
nitrite (Nit, E) or 75 µM resveratrol (Res, F). Control cells were incubated with serum free 
medium alone. Mean ± SEM of six independent experiments. *P < 0.05 versus control. 
#
P < 
0.05 versus corresponding group with TNF-α/CHX alone. 
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Fig. (4). Influence of 0.1-1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 6 h, on 
caspase-3/7 activity (as % of control) in the absence and presence of 1 µM bilirubin (BR, A), 
100 µM CORM-A1 (B), 10 mM nitrite (Nit, C) or 75 µM resveratrol (Res, D). Control cells 
were incubated with serum free medium alone. Mean ± SEM of six independent experiments. 
*P < 0.05 versus control. 
#
P < 0.05 versus corresponding group with TNF-α/CHX alone. 
 
Fig. (5). Influence of 0.1 and 1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 6 h, on 
apoptosis in the absence and presence of 1 µM bilirubin (BR, A), 100 µM CORM-A1 (B), 10 
mM nitrite (Nit, C) or 75 µM resveratrol (Res, D). Control cells were incubated with serum 
free medium alone. Mean ± SEM of three independent experiments. *P < 0.05 versus control. 
#
P < 0.05 versus corresponding group with TNF-α/CHX alone. 
 
Fig. (6). Influence of 0.1-1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 6 h, on 
cellular glutathione (GSH; as % of control) in the absence and presence of 1 µM bilirubin 
(BR, A), 100 µM CORM-A1 (B), 10 mM nitrite (Nit, C) or 75 µM resveratrol (Res, D). 
Control cells were incubated with serum free medium alone. Mean ± SEM of six independent 
experiments. *P < 0.05 versus control. 
#
P < 0.05 versus corresponding group with  
TNF-α/CHX alone. 
 
Fig. (7). Influence of 1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 3 h, on 
intracellular ROS levels in the absence and presence of 1 µM bilirubin (BR), 100 µM CORM-
A1, 10 mM nitrite (Nit) or 75 µM resveratrol (Res). Control cells were incubated with serum 
free medium alone. Mean ± SEM of four independent experiments. *P < 0.05 versus control. 
#
P < 0.05 versus 1 ng·mL
-1
 TNF-α/10 µg·mL-1 CHX alone. 
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Fig. (8). Influence of 1 ng·mL
-1
 TNF-α with 10 µg·mL-1 CHX, incubated for 3 h, on HO-1 
protein expression (relative to β-tubulin) in the absence and presence of 10 µM cobalt 
protoporphyrin (CoPP), 100 µM CORM-A1, 1 µM bilirubin (BR), 75 µM resveratrol (Res) or 
10 mM nitrite (Nit). Control cells were incubated with serum free medium alone. The 
influence of 20 ng·mL
-1
 TNF-α with 25 µg·mL-1 CHX and DMSO, the solvent of Res was 
also studied. Mean ± SEM of three independent experiments. *P < 0.05 versus control. 
#
P < 
0.05 versus 1 ng·mL
-1
 TNF-α/10 µg·mL-1 CHX alone. Representative immunoblots are shown 
at the top of the figure. 
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Fig. (2) 
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Fig. (3-i) 
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Fig. (3-ii) 
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Fig. (4) 
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Fig. (5) 
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Fig. (6) 
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Fig. (7) 
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Fig. (8) 
 
 
 
